2 Feb 2015: Motif Bio, a developer of antibiotics is seeking to raise £4-£16mln by listing on AIM, valuing the company at up to £60 Million. CEO Graham Lumsden says it offers investors the opportunity to be a part of an ‘exciting’ $44bln market.
2 Feb 2015: Motif Bio, a developer of antibiotics is seeking to raise £4-£16mln by listing on AIM, valuing the company at up to £60 Million. CEO Graham Lumsden says it offers investors the opportunity to be a part of an ‘exciting’ $44bln market.